Aliskiren: Just a New Drug for Few Selected Patients or an Innovative Molecule Predestinated to Replace Arbs and Ace-Inhibitors?

by Elena Raccuglia, Giovanni Fazio, Salvatore Novo
Published 2009-11-01

Novo, S. et al. Aliskiren: Just a New Drug for Few Selected Patients or an Innovative Molecule Predestinated to Replace Arbs and Ace-Inhibitors? Pharmaceuticals 2009, 2, 118-124

by Giuseppina Novo, Elena Raccuglia, Antonino Mignano, Salvatore Novo, Giovanni Fazio
Published 2011-09-01

Peripheral artery disease: potential role of ACE-inhibitor therapy

by Giuseppe Coppola, Giuseppe Romano, Egle Corrado, Rosa Maria Grisanti, Salvatore Novo
Published 2008-12-01

Zofenopril and ramipril in patients with left ventricular systolic dysfunction after acute myocardial infarction: A propensity analysis of the Survival of Myocardial Infarction Lon...

by Claudio Borghi, Stefano Omboni, Salvatore Novo, Dragos Vinereanu, Giuseppe Ambrosio, Ettore Ambrosioni
Published 2016-09-01

Five-year prospective study on cardiovascular events, in patients with erectile dysfunction and hypotestosterone

by Rosanna Iacona, Vito Bonomo, Mariaconcetta Di Piazza, Angela Sansone, Manuela Usala, Salvatore Novo, Carlo Pavone
Published 2017-12-01

Rupture of Aneurysm of Valsalva Sinus and Aortopathy in Bicuspid Aortic Valve: A Case Report and Review of Literature

by Patrizia Carità, Massimo Verdecchia, Elisabetta Mancini, Giovanni Ferro, Marco Guglielmo, Egle Corrado, Salvatore Novo, Mauro Pepi, Gianluca Pontone
Published 2016-01-01

Nutraceuticals and dyslipidaemia: Beyond the common therapeutics

by Pietro Scicchitano, Matteo Cameli, Maria Maiello, Pietro Amedeo Modesti, Maria Lorenza Muiesan, Salvatore Novo, Pasquale Palmiero, Pier Sergio Saba, Roberto Pedrinelli, Marco Matteo Ciccone
Published 2014-01-01